Without prejudice to Directive 2002/46/EC, the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as specified in Annex I to this Decision may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general adult population with a maximum dose established in Annex II to this Decision.
The designation of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger authorised by this Decision on the labelling of the foodstuffs shall be ‘prolyl oligopeptidase’.
This Decision is addressed to DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.
ANNEX ISupplementary provisions
ANNEX I
Specifications of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger
Specification of the enzyme
Systematic name
Prolyl oligopeptidase
Synonyms
Prolyl endopeptidase, proline-specific endopeptidase, endoprolylpeptidase
Molecular weight
66 kDa
Enzyme Commission number
EC 3.4.21.26
CAS number
72162-84-6
Source
A genetically modified strain of Aspergillus niger (GEP-44)
Description : Prolyl oligopeptidase is available as an enzyme preparation containing approximately 30 % maltodextrin.
Specifications of the enzyme preparation of prolyl oligopeptidase
Parameter
Specifications Limits
Activity
> 580 000 PPI ( 1 ) /g (> 34,8 PPU ( 2 ) /g)
Appearance
Microgranulate
Colour
Off-white to orange yellowish. The colour may change from batch to batch
Dry Matter
> 94 %
Gluten
< 20 ppm
Heavy metals
Total heavy metals (as lead)
≤ 10 mg/kg
Lead
≤ 1,0 mg/kg
Arsenic
≤ 1,0 mg/kg
Cadmium
≤ 0,5 mg/kg
Mercury
≤ 0,1 mg/kg
Microbiological specifications
Total aerobic plate count
≤ 10 3 CFU/g
Total yeasts and moulds
≤ 10 2 CFU/g
Sulphite reducing anaerobes
≤ 30 CFU/g
Enterobacteriaceae
< 10 CFU/g
Salmonella
Absent in 25 g
Escherichia coli
Absent in 25 g
Staphylococcus aureus
Absent in 10 g
Pseudomonas aeruginosa
Absent in 10 g
Listeria monocytogenes
Absent in 25 g
Antimicrobial activity
Absent
Mycotoxins
Below limits of detection: Aflatoxin B1, B2, G1, G2 (< 0,25 μg/kg), total Aflatoxins (< 2,0 μg/kg), Ochratoxin A (< 0,20 μg/kg), T-2 Toxin (< 5 μg/kg), Zearalenone (< 2,5 μg/kg), Fumonisin B1 and B2 (< 2,5 μg/kg)
( 1 ) PPI — Protease Picomole International.
( 2 ) PPU — Prolyl Peptidase Units or Proline Protease Units.
ANNEX IISupplementary provisions
ANNEX II
Authorised uses of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger
Food category
Maximum dose
Food supplements as defined in Directive 2002/46/EC
120 PPU ( 1 ) /day (2,7 g of enzyme preparation/day) (2 × 10 6 PPI ( 2 ) /day) for general adult population
( 1 ) PPU — Prolyl Peptidase Units or Proline Protease Units.
( 2 ) PPI — Protease Picomole International.